Bank Of America Corp Allogene Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,163,743 shares of ALLO stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,163,743

Previous 583,925 99.3%

Holding current value

$2.53 Million

Previous $1.63 Million 51.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.84 - $3.22 $1.07 Million - $1.87 Million	579,818 Added 99.3%	1,163,743 $2.48 Million
Q3 2024 Nov 14, 2024	BUY	$2.08 - $3.5 $314,541 - $529,277	151,222 Added 34.95%	583,925 $1.63 Million
Q2 2024 Aug 14, 2024	BUY	$2.23 - $4.38 $63,155 - $124,045	28,321 Added 7.0%	432,703 $1.01 Million
Q1 2024 May 15, 2024	BUY	$2.92 - $5.63 $214,602 - $413,771	73,494 Added 22.21%	404,382 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $876,844 - $1.35 Million	-384,581 Reduced 53.75%	330,888 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $1.43 Million - $2.13 Million	-316,195 Reduced 30.65%	715,469 $3.56 Million
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $822,555 - $1.37 Million	167,186 Added 19.34%	1,031,664 $5.1 Million
Q4 2022 Feb 10, 2023	BUY	$5.62 - $11.11 $2.81 Million - $5.56 Million	500,817 Added 137.72%	864,478 $5.44 Million
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $987,304 - $1.65 Million	95,669 Added 35.7%	363,661 $3.93 Million
Q2 2022 Aug 12, 2022	SELL	$6.78 - $12.28 $2.11 Million - $3.83 Million	-311,934 Reduced 53.79%	267,992 $3.06 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $2.37 Million - $4.74 Million	310,292 Added 115.08%	579,926 $5.28 Million
Q4 2021 Feb 08, 2022	BUY	$13.13 - $24.52 $2.78 Million - $5.19 Million	211,768 Added 365.96%	269,634 $4.02 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $2.21 Million - $2.91 Million	-105,235 Reduced 64.52%	57,866 $1.49 Million
Q2 2021 Sep 13, 2021	BUY	$23.49 - $35.8 $3.83 Million - $5.84 Million	163,101 New	163,101 $4.25 Million

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $312M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Allogene Therapeutics, Inc. Transaction History